Skip to main content
. 2024 Nov 14;10(1):2419779. doi: 10.1080/20565623.2024.2419779

Figure 4.

Figure 4.

Time-course changes in each biomarker regarding the efficacy of HDM SLIT in patients with AD with allergic rhinitis.

(A, B, D–G) Changes in each biomarker from baseline to 12 and 24 months after the start of HDM SLIT. (C) Changes in each biomarker from baseline to 12 months after the start of HDM SLIT. (H & I) Changes in the surface marker ratio in the basophil activation test from baseline to 12 and 24 months after the start of HDM SLIT. To calculate the responsiveness of basophils, we divided the antigen stimulation MFI by the anti-IgE stimulation MFI and presented it as the ‘CD203c ratio’ or ‘CD63 ratio’.

Der p s-IgE: Dermatophagoides pteronyssinus specific-IgE; Der p s-IgG4: Dermatophagoides pteronyssinus specific-IgG4; Der f s-IgE: Dermatophagoides farinae specific-IgE; Der f s-IgG4: Dermatophagoides farinae specific-IgG4; IgE: Immunoglobulin E; IgG4: Immunoglobulin G subclass 4; TARC: Thymus and activation-regulated chemokine.